Zerillo Jeffrey
Senior VP Operations
Sale 10b5-1
- Shares
- 351
- Price
- $52.28
- Value
- $18,350
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•35 filings
PBH
Prestige Consumer Healthcare Inc.
No net buying or selling imbalance over the last 3 months
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$424,424
2 distinct insiders
Highlighted alerts
3
5 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get PBH insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
PBH overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
47
Raw transactions
Everything returned by the filing
8
Voluntary view
P/S trades after deterministic checks
39
Administrative noise
Stored, never alerted
9
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- A
- Shares
- 2,981
- Price
- $0.00
- Footnotes
- 1
The Reporting Person received 2,981 restricted stock units equal to $155,000 divided by the closing stock price of $52.00 on August 4, 2026, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Zerillo Jeffrey
Senior VP Operations
Sale 10b5-1
- Shares
- 305
- Price
- $54.36
- Value
- $16,580
Zerillo Jeffrey
Senior VP Operations
SaleAlert
- Shares
- 1,207
- Price
- $54.99
- Value
- $66,373
Zerillo Jeffrey
Senior VP Operations
Sale 10b5-1
- Shares
- 346
- Price
- $55.32
- Value
- $19,141
Zerillo Jeffrey
Senior VP Operations
SaleAlert
- Shares
- 1,000
- Price
- $65.93
- Value
- $65,930
Zerillo Jeffrey
Senior VP Operations
Sale 10b5-1
- Shares
- 281
- Price
- $60.00
- Value
- $16,860
Zerillo Jeffrey
Senior VP Operations
Sale 10b5-1
- Shares
- 719
- Price
- $60.00
- Value
- $43,140
BYOM JOHN E
Director
SaleAlert
- Shares
- 3,000
- Price
- $59.35
- Value
- $178,050
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| May 11, 2026 | Zerillo Jeffrey Senior VP Operations | Sale | 351 | $52.28 | $18,350 | |
| May 07, 2026 | Zerillo Jeffrey Senior VP Operations | Sale | 305 | $54.36 | $16,580 | |
| May 05, 2026 | Zerillo Jeffrey Senior VP Operations | Sale | 1,207 | $54.99 | $66,373 | |
| May 05, 2026 | Zerillo Jeffrey Senior VP Operations | Sale | 346 | $55.32 | $19,141 | |
| Feb 11, 2026 | Zerillo Jeffrey Senior VP Operations | Sale | 1,000 | $65.93 | $65,930 | |
| Dec 01, 2025 | Zerillo Jeffrey Senior VP Operations | Sale | 281 | $60.00 | $16,860 | |
| Nov 28, 2025 | Zerillo Jeffrey Senior VP Operations | Sale | 719 | $60.00 | $43,140 | |
| Nov 25, 2025 | BYOM JOHN E Director | Sale | 3,000 | $59.35 | $178,050 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.